Latham & Watkins LLP represents Jefferies LLC and Leerink Partners LLC acting as placement agents in the financing. Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering. AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
You must be a Standard 1 Year member to access this content.
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
